| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 401 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 395 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 377 | 2024 |
| Photosensitizers in antibacterial photodynamic therapy: An overview J Ghorbani, D Rahban, S Aghamiri, A Teymouri, A Bahador Laser therapy 27 (4), 293-302, 2018 | 322 | 2018 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 258 | 2024 |
| Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects AJ Abadi, S Mirzaei, MK Mahabady, F Hashemi, A Zabolian, F Hashemi, ... Phytotherapy Research 36 (1), 189-213, 2022 | 155 | 2022 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 82 | 2024 |
| Opportunities and challenges of the tag-assisted protein purification techniques: Applications in the pharmaceutical industry MM Gomari, N Saraygord-Afshari, M Farsimadan, N Rostami, S Aghamiri, ... Biotechnology advances 45, 107653, 2020 | 78 | 2020 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 68 | 2023 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 65 | 2024 |
| Nanotechnological approaches in prostate cancer therapy: integration of engineering and biology M Ashrafizadeh, S Aghamiri, SC Tan, A Zarrabi, E Sharifi, N Rabiee, ... Nano Today 45, 101532, 2022 | 64 | 2022 |
| The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis HV Kord, GM Tinsley, HO Santos, H Zand, A Nazary, S Fatahi, Z Mokhtari, ... Clinical Nutrition 40 (4), 1811-1821, 2021 | 61 | 2021 |
| Nanoparticles-mediated CRISPR/Cas9 delivery: recent advances in cancer treatment S Aghamiri, S Talaei, AA Ghavidel, F Zandsalimi, S Masoumi, ... Journal of Drug Delivery Science and Technology 56, 101533, 2020 | 55 | 2020 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 49 | 2023 |
| Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections S Najafi, SC Tan, S Aghamiri, P Raee, Z Ebrahimi, ZK Jahromi, Y Rahmati, ... Biomedicine & pharmacotherapy 148, 112743, 2022 | 49 | 2022 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases, 2024 | 46 | 2024 |
| Gene regulation by antisense transcription: A focus on neurological and cancer diseases S Najafi, SC Tan, P Raee, Y Rahmati, Y Asemani, EHC Lee, ... Biomedicine & Pharmacotherapy 145, 112265, 2022 | 45 | 2022 |
| Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian, M Hashemi, M Entezari, ... Life Sciences 288, 119948, 2022 | 44 | 2022 |
| Recent insights into the roles of circular RNAs in human brain development and neurologic diseases S Najafi, SMA Zarch, J Majidpoor, S Pordel, S Aghamiri, MF Rasul, ... International Journal of Biological Macromolecules 225, 1038-1048, 2023 | 43 | 2023 |
| Antimicrobial peptides as potential therapeutics for breast cancer S Aghamiri, F Zandsalimi, P Raee, MA Abdollahifar, SC Tan, TY Low, ... Pharmacological Research 171, 105777, 2021 | 42 | 2021 |
